This German government agency offers teleworking and phased retirement

Winning Year: 2011, 2010
Industry: Government
Location: Nürnberg, Germany
Website: www.arbeitsagentur.de 
Employees: 95,900; Percentage over age 50: 35.2

Employees at Germany's federal employment agency, Bundesagentur für Arbeit (BA), benefit from a wide variety of flexible work arrangements and long-term working time accounts that provide opportunities for extended leaves of absence. These options are especially beneficial to older workers caring for family members or transitioning into retirement. BA also regularly re-employs retired staff members with specific skill sets for special projects. More recently, BA launched a "family service," which offers caregiving consulting as well as emergency day care services.

See also: How the 2011 Best Employers winners were selected.

About Best Employers

• Best Employers for Workers Over 50. Read
• 2011 Best Employers for Workers Over 50 Winners.Read
• 2011 Judges. Read
• 2011 AARP Best Employers for Workers Over 50 - International.Read

Lifelong Learning and Training: Managers conduct annual performance and development dialogues with each employee. This dialogue serves to determine the status of the employee's competencies and shows additional development opportunities. Individualcareer ambitions and life plans are taken into account explicitly. 

In addition, BA regularly carries out a differentiated age structure analysis in order to optimize staff planning. 

The BA's long-term working hours accounts are another essential element of lifelong learning. The concept allows an employee to accumulate up to 200 hours each year that can be used for earlyretirement, phased retirement, sabbaticals, training, and family caregiving responsibilities. 

Flexible Work Arrangements: Five hundred flextime models are in use. Part-time employment, including in leadership positions, as well as telework have enjoyed a strong uptake. Telework is especially open to employees with family burdens (caring for children, old or disabled persons). Over 3,400 employees make use of it. 

The teleworking option now is explicitly open to older employees in a later phase of their professional career to promote employability and jobsatisfaction of this target group in particular. The target group of employees on long-term sick leave (more than six weeks) has been added as a means of integration management. The BA has introduced this opportunity to be able to respond quickly to special personal or family-related requirements.

The BA launched a professional family service in 2011. It provides employees with:

• Information and consulting on childcare as well as care of relatives
• Support benefits in care situations and placement of childcare
• Emergency care when the regular care suddenly becomes unavailable. 

Health Promotion and Protection: The BA's in-house healthmanagement system (BGM) takes a preventive approach that promotes personal responsibility and initiative. Fields of activity include occupational safety, health promotion, and integration management for long-term sick employees. 

Other campaigns to promote a healthy lifestyle include:

• Special theme health days
• Screenings and eye tests
• Massage treatment at the workplace
• Stress management trainings
• Initiatives to stop smoking
• A screen saver with exercises for the workplace 
  

In 2011, the central health working group is focusing on the themes of absentee management, mental stress at the workplace and psychological disorders. 

Diversity Promotion: Current diversity activities include:

• An action program to reach the 8.7 percent target quota for severely disabled employees (current quota 8.5 percent)
• Regular information campaigns to sensitize managers and staff to diversity topics
• Diversity management is integrated in the BA's internal training and in courses
• Meetings with the target groups of our fields of action on a regular basis to foster direct exchange. This is an important way for BA to gain insights for its HR policy. Afterwards BA systematically discusses these insights with senior executives in order to promote and sensitize for the prevailing field of action. 
  

Recruitment: Job advertisements aimed at university graduates state explicitly that a "comparable qualification" in the form of many years' vocational experience in the respective area will be regarded as of equal value and can replace the formal qualification. This way, the BA expresses its appreciation of the vocational and life experience of older applicants. The older applicants' equality of opportunity is guaranteed in the framework of internal recruitment as well.

This year the BA has added the "employment quota for older employees" to the list of business goals for its internal HR services. The target quota is for 10 percent of all externally recruited employees to be older than 50 years. In 2009, the employment quota of persons over the age of 50 was 7.75 percent.

BA makes use of the specialist knowledge of older employees who have already retired. For special projects/situations, it is possible to recruit former employees for a limited period. One example is the initiative "Taking the Lead", which we started to strengthen the management capability of team leaders. Older or retired persons are part of the trainer team, in order to pass on their experiences as team leaders to younger team leaders.

Best drugs

List of bestselling drugs

From Wikipedia, the free encyclopedia

This article is outdated. Please update this article to reflect recent events or newly available information. Please see the talk page for more information. (May 2011)

The following is a list of the top 200 pharmaceutical products ranked by sales in U.S. dollars for 2006.

Rank 2006	Brand Name(s)	Generic Name	Sales 2006(USD millions)	Change from 2005	Company(ies)	Disease/Medical Use	First Approval Date	Patent Expiration Date[1][2]
1	Lipitor	Atorvastatin	14,385	7%	Pfizer	Cholesterol	Dec-1996	Nov-2011
2	Advair, Seretide	Fluticasone +Salmeterol	6,129	12%	GlaxoSmithKline	Asthma	Aug-2000	Mar-2012
3	Plavix, Iscover	Clopidogrel	6,057	-5%	Bristol-Myers Squibb/Sanofi-Aventis	Thrombotic events	Nov-1997	Nov-2011
4	Nexium	Esomeprazole	5,182	12%	AstraZeneca	Gastrointestinal disorders	Mar-2000	Sep-2007
5	Norvasc	Amlodipine	4,866	3%	Pfizer	Hypertension	Jul-1992	Jul-2006
6	Remicade	Infliximab	4,428	23%	Johnson & Johnson,Schering-Plough,Mitsubishi Tanabe Pharma	Crohn's disease, Rheumatoid arthritis	Aug-1998	n/a
7	Enbrel	Etanercept	4,379	20%	Amgen	Rheumatoid arthritis	Nov-1998	Oct-2012
8	Zyprexa	Olanzapine	4,364	4%	Eli Lilly and Company	Psychosis	Sep-1996	Jun-2013
9	Diovan	Valsartan	4,223	15%	Novartis	Hypertension	Dec-1996	Jul-2011
10	Risperdal	Risperidone	4,183	18%	Johnson & Johnson	Psychosis	Dec-1993	Dec-2007
11	Aranesp	Darbepoetin alfa	4,121	26%	Amgen	Anemia	Jun-2001	Mon-20XX
12	Rituxan, MabThera	Rituximab	3,861	16%	Roche, Genentech,Biogen Idec, Chugai Pharmaceutical	Non-Hodgkin's lymphoma, Rheumatoid arthritis	Nov-1997	Mon-20XX
13	Effexor	Venlafaxine	3,722	8%	Wyeth	Depression, Anxiety disorders	Dec-1993	Dec-2007
14	Protonix, Pantozol, Pantoloc	Pantoprazole	3,621	4%	Wyeth, Altana, Solvay	Gastrointestinal disorders	Feb-2000	Mon-20XX
15	Singulair	Montelukast	3,579	20%	Merck & Co.	Asthma	Feb-1998	Feb-2012
16	Seroquel	Quetiapine	3,560	23%	AstraZeneca	Schizophrenia	Sep-1997	Sep-2011
17	Prevacid, Takepron	Lansoprazole	3,425	3%	TAP Pharmaceuticals,Takeda Pharmaceutical	Gastrointestinal disorders	May-1995	May-2009
18	Procrit, Eprex	Erythropoietin	3,180	-4%	Johnson & Johnson	Anemia	Dec-1990	Mon-20XX
19	Cozaar, Hyzaar	Losartan	3,163	4%	Merck & Co.	Hypertension	Apr-1995	Mon-20XX
20	Fosamax	Alendronate	3,134	-2%	Merck & Co.	Osteoporosis	Sep-1995	Mon-20XX
21	Herceptin	Trastuzumab	3,134	83%	Roche, Genentech,Chugai Pharmaceutical	Breast cancer	Sep-1998	Mon-20XX
22	Lovenox, Clexane	Enoxaparin	3,059	14%	Sanofi-Aventis	Deep-vein thrombosis	Mar-1993	Dec-2004
23	Avandia, Avandamet, Avandaryl	Rosiglitazone	3,043	26%	GlaxoSmithKline	Type 2 diabetes	May-1999	Sep-2011
24	Actos	Pioglitazone	2,880	25%	Takeda Pharmaceutical,Eli Lilly and Company	Type 2 diabetes	Jul-1999	May-2007
25	Zocor	Simvastatin	2,803	-36%	Merck & Co.	Cholesterol	Dec-1991	Dec-2005
26	Copaxone	Glatiramer	2,757	19%	Teva Pharmaceutical Industries, Sanofi-Aventis	Multiple sclerosis	Dec-1996	Mon-20XX
27	AcipHex, Pariet	Rabeprazole	2,729	-4%	Eisai, Johnson & Johnson	Gastrointestinal disorders	Aug-1999	May-2013
28	Neulasta	Filgrastim	2,710	18%	Amgen	Neutropenia	Jan-2002	Mon-20XX
29	Lexapro, Cipralex	Escitalopram	2,696	16%	Forest Laboratories, H. Lundbeck	Depression, Anxiety disorders	Aug-2002	Sep-2011
30	Gleevec, Glivec	Imatinib	2,554	18%	Novartis	Leukemia	May-2001	Jan-2015
31	Ambien, Stilnox	Zolpidem	2,545	33%	Sanofi-Aventis	Insomnia	Dec-1992	Oct-2006
32	Aricept	Donepezil	2,519	24%	Pfizer	Alzheimer's disease	Nov-1996	Nov-2010
33	Epogen	Erythropoietin	2,511	2%	Amgen	Anemia	Jun-1989	Mon-20XX
34	Zyrtec, Cirrus	Cetirizine	2,377	9%	Pfizer, UCB, Daiichi Sankyo	Allergic rhinitis	Dec-1995	Jun-2007
35	Avapro, Aprovel, Avalide	Irbesartan	2,372	13%	Sanofi-Aventis, Bristol-Myers Squibb	Hypertension	Sep-1997	Sep-2011
36	Avastin	Bevacizumab	2,364	78%	Roche, Genentech	Colorectal cancer	Feb-2004	Mon-20XX
37	Taxotere	Docetaxel	2,201	9%	Sanofi-Aventis	Cancer	Oct-1995	May-2010
38	Eloxatin, Eloxatine	Oxaliplatin	2,127	8%	Sanofi-Aventis	Colorectal cancer	Aug-2002	Aug-2016
39	Zoloft	Sertraline	2,110	-35%	Pfizer	Depression, Anxiety disorders	Dec-1991	Dec-2005
40	Tamiflu	Oseltamivir	2,096	69%	Roche, Chugai Pharmaceutical, Hetero Drugs	Influenza	Oct-1999	Mon-20XX
41	Lantus	Insulin analog	2,093	37%	Sanofi-Aventis	Type 2 diabetes and type 1 diabetes	Apr-2000	Dec-2011
42	Crestor	Rosuvastatin	2,049	61%	AstraZeneca, Shionogi	Cholesterol	Nov-2002	Jan-2016
43	Humira	Adalimumab	2,044	46%	Abbott Laboratories	Rheumatoid arthritis	Dec-2002	Dec-2016
44	Celebrex	Celecoxib	2,039	18%	Pfizer	Osteoarthritis and rheumatoid arthritis	Dec-1998	Mon-20XX
45	Topamax	Topiramate	2,027	21%	Johnson & Johnson	Seizures	Dec-1996	Sep-2008
46	Prevnar	vaccine	1,961	30%	Wyeth	Pneumococcal disease	Feb-2000	Jan-2007
47	Vytorin	Ezetimibe +Simvastatin	1,955	90%	Merck & Co., Schering-Plough	Cholesterol	Jul-2004	Mon-20XX
48	Zetia	Ezetimibe	1,929	38%	Merck & Co., Schering-Plough	Cholesterol	Oct-2002	Oct-2016
49	Wellbutrin	Bupropion	1,926	26%	GlaxoSmithKline, Biovail	Depression, Seasonal affective disorder (SAD)	Aug-2003	May-1994
50	Abilify	Aripiprazole	1,900	1%	Otsuka Pharmaceutical,Bristol-Myers Squibb	Psychosis, Depression	Nov-2002	Oct-2014
51	Lamictal	Lamotrigine	1,843	19%	GlaxoSmithKline	Seizures	Dec-1994	Jul-2008
52	Toprol, Seloken	Metoprolol	1,795	3%	AstraZeneca	Hypertension	Jan-1992	Mon-20XX
53	NeoRecormon, Epogin	Erythropoietin	1,777	-1%	Roche, Chugai Pharmaceutical	Anemia	Jul-1997	Mon-20XX
54	Atacand, Blopress	Candesartan	1,768	8%	Takeda Pharmaceutical,AstraZeneca	Hypertension	Oct-1997	Jul-2012
55	Spiriva	Tiotropium	1,735	45%	Boehringer Ingelheim	Chronic obstructive pulmonary disease	Apr-2002	Jan-2018
56	Avonex	Interferon beta-1a	1,707	11%	Biogen Idec	Multiple sclerosis	May-1996	Mon-20XX
57	Viagra	Sildenafil	1,657	1%	Pfizer	Erectile dysfunction	Mar-1998	Mar-2012
58	Micardis	Telmisartan	1,645	35%	Boehringer Ingelheim,Astellas Pharma	Hypertension	Nov-1998	Mon-20XX
59	Actonel	Risedronate	1,619	-4%	Procter & Gamble, Sanofi-Aventis	Osteoporosis	Mar-1998	Mon-20XX
60	Lupron, Leuplin	Leuprolide	1,579	1%	Takeda Pharmaceutical,TAP Pharmaceuticals	Prostate cancer	Jan-1989	Jan-1996
61	TriCor, Lipanthyl	Fenofibrate	1,567	38%	Abbott Laboratories,Solvay	Cholesterol	Feb-1998	Mon-20XX
62	Zofran	Ondansetron	1,567	3%	GlaxoSmithKline	Nausea and vomiting	Dec-1992	Jan-2005
63	Valtrex	Valaciclovir	1,563	24%	GlaxoSmithKline	Herpes	Jun-1995	Jun-2009
64	Levaquin, Floxin	Levofloxacin	1,530	3%	Johnson & Johnson	Bacterial infections	Dec-1996	Dec-2010
65	Arimidex	Anastrozole	1,508	28%	AstraZeneca	Breast cancer	Dec-1995	Dec-2009
66	Prograf	Tacrolimus	1,499	20%	Astellas Pharma	Transplant rejection	Apr-1993	Apr-2008
67	CellCept	Mycophenolate mofetil	1,470	8%	Roche, Chugai Pharmaceutical	Transplant rejection	May-1995	May-2009
68	Xalatan, Xalacom	Latanoprost	1,453	6%	Pfizer	Intraocular pressure	Jun-1996	Jul-2006
69	Rebif	Interferon beta-1a	1,452	14%	Serono	Multiple sclerosis	Feb-1998	Mon-20XX
70	Coreg	Carvedilol	1,441	38%	GlaxoSmithKline	Hypertension	Sep-1995	Mar-2007
71	Gemzar	Gemcitabine	1,408	5%	Eli Lilly and Company	Cancer	May-1996	May-2010
72	Prilosec, Losec	Omeprazole	1,371	-17%	AstraZeneca	Gastrointestinal disorders	Sep-1989	Apr-2001
73	Benicar, Olmetec	Olmesartan	1,370	73%	Daiichi Sankyo, Forest Laboratories	Hypertension	Apr-2002	Apr-2016
74	Lotrel	Amlodipine +Benazepril	1,352	26%	Novartis	Hypertension	Jun-1999	Mon-20XX
75	Cymbalta	Duloxetine	1,316	94%	Eli Lilly and Company	Depression, Anxiety disorders	Aug-2004	Jun-2013
76	Imitrex, Imigran	Sumatriptan	1,315	4%	GlaxoSmithKline	Migraine	Dec-1992	Dec-2006
77	Depakote	Valproate semisodium	1,308	19%	Abbott Laboratories	Seizures	Mar-1983	Mon-20XX
78	Humalog	Insulin analog	1,300	8%	Eli Lilly and Company	Diabetes	Apr-1996	Mon-20XX
79	Duragesic	Fentanyl	1,295	-18%	Johnson & Johnson	Pain	Aug-1990	Mon-20XX
80	Pulmicort	Budesonide	1,292	11%	AstraZeneca	Asthma	Jun-1997	Mon-20XX
81	Zometa	Zoledronate	1,283	5%	Novartis	Hypercalcemia	Aug-2000	Mon-20XX
82	Betaseron, Betaferon	Interferon beta-1b	1,245	14%	Schering AG	Multiple sclerosis	Jul-1993	Mon-20XX
83	Delix, Tritace	Ramipril	1,227	-3%	Sanofi-Aventis	Hypertension	Jul-2000	Mon-20XX
84	Flovent, Flixotide	Fluticasone	1,219	5%	GlaxoSmithKline	Asthma	Mar-1996	Mon-20XX
85	Neupogen	Filgrastim	1,213	0%	Amgen	Neutropenia	Feb-1991	Mon-20XX
86	Casodex	Bicalutamide	1,206	7%	AstraZeneca	Prostate cancer	Oct-1995	Mon-20XX
87	Pravachol	Pravastatin	1,197	-47%	Bristol-Myers Squibb	Cholesterol	Oct-1991	Mon-20XX
88	Truvada	Tenofovir +Emtricitabine	1,194	110%	Gilead Sciences	HIV infection	Aug-2004	Mon-20XX
89	Symbicort	Budesonide +Formoterol	1,184	18%	AstraZeneca	Asthma	Aug-2000	Mon-20XX
90	Pegasys	Pegylated interferon alfa-2a	1,171	5%	Roche, Chugai Pharmaceutical	Hepatitis C	Jun-2002	Mon-20XX
91	Evista	Raloxifene	1,159	4%	Eli Lilly and Company,Chugai Pharmaceutical	Osteoporosis	Dec-1997	Mon-20XX
92	Flomax	Tamsulosin	1,158	28%	Boehringer Ingelheim	Benign prostatic hypertrophy	Oct-1997	Mon-20XX
93	Lyrica	Pregabalin	1,156	297%	Pfizer	Neuropathic pain	Jul-2004	Mon-20XX
94	Paxil, Seroxat	Paroxetine	1,147	3%	GlaxoSmithKline	Depression, Anxiety disorders	Dec-1992	Mon-20XX
95	Kaletra	Lopinavir	1,135	13%	Abbott Laboratories	HIV infection	Mar-2001	Mon-20XX
96	Detrol	Tolterodine	1,100	11%	Pfizer	Overactive bladder	Mar-1998	Mon-20XX
97	Harnal	Tamsulosin	1,085	-8%	Astellas Pharma	Benign prostatic hypertrophy	Jul-1992	Mon-20XX
98	Erbitux	Cetuximab	1,075	56%	Bristol-Myers Squibb,Merck KGaA	Colorectal cancer	Feb-2004	Mon-20XX
99	Synagis	Palivizumab	1,065	-9%	MedImmune	Respiratory syncytial virus	Jun-1998	Mon-20XX
100	Augmentin	Co-amoxiclav	1,055	-13%	GlaxoSmithKline	Bacterial infections	Aug-1984	Mon-20XX
101	Premarin, Prempro, Premphase	Estrogen	1,051	16%	Wyeth	Menopausal symptoms	Nov-1995	Mon-20XX
102	Ortho contraceptives	Estrogen +Progesterone	1,016	-11%	Johnson & Johnson	Contraception	Apr-1984	Mon-20XX
103	Zoladex	Goserelin	1,008	0%	AstraZeneca	Prostate cancer	Dec-1989	Mon-20XX
104	Cerezyme	Imiglucerase	1,007	8%	Genzyme	Gaucher disease	Apr-1991	Mon-20XX
105	Cravit	Levofloxacin	1,002	2%	Daiichi Sankyo, Santen Pharmaceutical	Bacterial infections	Jun-1993	Mon-20XX
106	Yasmin	Drospirenone	998	36%	Schering AG	Prevention of pregnancy	Aug-2000	Mon-20XX
107	Kogenate	Recombinant factor VIII	989	19%	Bayer	Hemophilia	Feb-1993	Mon-20XX
108	Botox	Botulin toxin	982	18%	Allergan	Cervical dystonia	Dec-1989	Mon-20XX
109	Lamisil	Terbinafine	978	-14%	Novartis	Fungal infections	Dec-1992	Mon-20XX
110	Combivir	Lamivudine +Zidovudine	977	-8%	GlaxoSmithKline	HIV infection	Sep-1997	Mon-20XX
111	Zosyn, Tazocin	Piperacillin	972	9%	Wyeth	Bacterial infections	Oct-1993	Mon-20XX
112	Cialis	Tadalafil	971	30%	Eli Lilly and Company,Lilly Icos	Erectile dysfunction	Nov-2002	Mon-20XX
113	Keppra	Levetiracetam	956	36%	UCB	Seizures	Nov-1999	Mon-20XX
114	NovoSeven	Factor VII	948	11%	Novo Nordisk	Bleeding due to hemophilia	Feb-1996	Mon-20XX
115	Infanrix, Pediarix	vaccine	945	21%	GlaxoSmithKline	Diphtheria, tetanus, and pertussis	Jan-1996	Mon-20XX
116	Nasonex	Mometasone	944	28%	Schering-Plough	Allergic rhinitis	Oct-1997	Mon-20XX
117	Reyataz	Atazanavir	931	34%	Bristol-Myers Squibb	HIV infection	Jan-2003	Mon-20XX
118	Concerta	Methylphenidate	930	20%	Johnson & Johnson	Attention-deficit hyperactivity disorder	Aug-2000	Mon-20XX
119	Humulin	Recombinant human insulin	925	-8%	Eli Lilly and Company	Diabetes	Oct-1982	Mon-20XX
120	Neoral, Sandimmun	Ciclosporin	918	-4%	Novartis	Transplant rejection	Jul-1995	Mon-20XX
121	Sandostatin	Somatostatin	915	2%	Novartis	Acromegaly	Oct-1988	Mon-20XX
122	Camptosar	Irinotecan	903	-1%	Pfizer	Colorectal cancer	Jun-1996	Mon-20XX
123	Engerix-B, Havrix, Twinrix	vaccine	886	10%	GlaxoSmithKline	Hepatitis	Aug-1989	Mon-20XX
124	Allegra, Telfast	Fexofenadine	864	-49%	Sanofi-Aventis	Allergic rhinitis	Jul-1996	Mon-20XX
125	Adderall	Amphetamine	864	18%	Shire Pharmaceuticals	Attention-deficit hyperactivity disorder	Oct-2001	Mon-20XX
126	Combivent	Ipratropium +Salbutamol	843	20%	Boehringer Ingelheim	Chronic obstructive pulmonary disease	Oct-1996	Mon-20XX
127	Peg-Intron	Pegylated interferon alfa-2b	837	11%	Schering-Plough	Hepatitis C	May-2000	Mon-20XX
128	Adalat	Nifedipine	825	0%	Bayer	Hypertension	Nov-1985	Mon-20XX
129	Avelox, Avalox	Moxifloxacin	822	17%	Bayer, Schering-Plough,Shionogi	Bacterial infections	Dec-1999	Mon-20XX
130	Mobic	Meloxicam	818	-66%	Boehringer Ingelheim,Daiichi Sankyo	Osteoarthritis and rheumatoid arthritis	Feb-1996	Mon-20XX
131	Biaxin	Clarithromycin	816	-23%	Abbott Laboratories	Bacterial infections	Oct-1991	Mon-20XX
132	Mevalotin	Pravastatin	799	-35%	Daiichi Sankyo	Cholesterol	Jun-1909	Mon-20XX
133	Ultane, Sevorane	Sevoflurane	799	-9%	Abbott Laboratories	Anesthesia	Jun-1995	Mon-20XX
134	Genotropin	Somatropin	795	-2%	Pfizer	Growth failure	Aug-1995	Mon-20XX
135	Sustiva	Efavirenz	791	16%	Bristol-Myers Squibb	HIV infection	Sep-1998	Mon-20XX
136	Zyvox	Linezolid	782	27%	Pfizer	Bacterial infections	Apr-2000	Mon-20XX
137	Xeloda	Capecitabine	775	22%	Roche, Chugai Pharmaceutical	Cancer	Jun-1909	Mon-20XX
138	Geodon, Zeldox	Ziprasidone	758	29%	Pfizer	Schizophrenia	Feb-2001	Mon-20XX
139	Cipro, Ciprobay	Ciprofloxacin	755	-6%	Bayer, Schering-Plough	Bacterial infections	Oct-1987	Mon-20XX
140	Provigil	Modafinil	735	43%	Cephalon	Sleepiness	Dec-1998	Mon-20XX
141	Lescol	Fluvastatin	725	-5%	Novartis	Cholesterol	Dec-1993	Mon-20XX
142	Clarinex, Aerius	Desloratadine	722	12%	Schering-Plough	Allergic rhinitis	Dec-2001	Mon-20XX
143	Femara	Letrozole	722	35%	Novartis, Chugai Pharmaceutical	Breast cancer	Jul-1997	Mon-20XX
144	Trileptal	Oxcarbazepine	721	17%	Novartis	Seizures	Nov-1999	Mon-20XX
145	Tracleer	Bosentan	717	42%	Actelion	Pulmonary arterial hypertension	Nov-2001	Mon-20XX
146	Primaxin	Imipenem +Cilastatin	705	-5%	Merck & Co.	Bacterial infections	Nov-1985	Mon-20XX
147	Temodar	Temozolomide	703	20%	Schering-Plough	Anaplastic astrocytoma	Aug-1999	Mon-20XX
148	Trusopt, Cosopt	Dorzolamide	697	13%	Merck & Co.	Intraocular pressure	Dec-1994	Mon-20XX
149	Voltaren	Diclofenac	690	0%	Novartis	Osteoarthritis and rheumatoid arthritis	Jul-1998	Mon-20XX
150	Viread	Tenofovir	689	-12%	Gilead Sciences	HIV infection	Oct-2001	Mon-20XX
151	Sifrol	Pramipexole	673	23%	Boehringer Ingelheim	Parkinson's disease	Oct-1997	Mon-20XX
152	Namenda	Memantine	660	30%	Forest Laboratories	Alzheimer disease	Oct-2003	Mon-20XX
153	Altace	Ramipril	653	18%	King Pharmaceuticals	Cardiovascular events	Jan-1991	Mon-20XX
154	Byetta	Exenatide	649	464%	Amylin Pharmaceuticals,Eli Lilly and Company	Type 2 diabetes	Apr-2005	Mon-20XX
155	Tarceva	Erlotinib	649	110%	Roche, Genentech	Non-small cell lung cancer	Nov-2004	Mon-20XX
156	Zithromax, Zmax	Azithromycin	638	-68%	Pfizer	Bacterial infections	Nov-1991	Mon-20XX
157	Omnicef	Cefdinir	637	29%	Abbott Laboratories	Bacterial infections	Dec-1997	Mon-20XX
158	Proscar	Finasteride	619	-16%	Merck & Co.	Benign prostatic hypertrophy	Jun-1992	Mon-20XX
159	Alimta	Pemetrexed	612	32%	Eli Lilly and Company	Non-small cell lung cancer	Feb-2004	Mon-20XX
160	Merrem	Meropenem	604	20%	AstraZeneca	Bacterial infections	Jun-1996	Mon-20XX
161	Forteo	Teriparatide	594	53%	Eli Lilly and Company	Osteoporosis	Nov-2002	Mon-20XX
162	Strattera	Atomoxetine	579	5%	Eli Lilly and Company	Attention-deficit hyperactivity disorder	Nov-2002	Mon-20XX
163	Actiq	Fentanyl	578	40%	Cephalon	Cancer pain	Nov-1998	Mon-20XX
164	Flonase, Flixonase	Fluticasone	575	-52%	GlaxoSmithKline	Allergic rhinitis	Oct-1994	Mon-20XX
165	Amaryl	Glimepiride	567	-33%	Sanofi-Aventis	Type 2 diabetes	Nov-1995	Mon-20XX
166	Lidoderm	Lidocaine	567	35%	Endo Pharmaceuticals	Pain	Mar-1999	Mon-20XX
167	Lunesta	Eszopiclone	567	72%	Sepracor	Insomnia	Dec-2004	Mon-20XX
168	Boniva, Bonviva	Ibandronate	565	454%	Roche, GlaxoSmithKline	Osteoporosis	Mar-2005	Mon-20XX
169	Taxol	Paclitaxel	563	-25%	Bristol-Myers Squibb	Cancer	Dec-1992	Mon-20XX
170	Zelnorm, Zelmac	Tegaserod	561	34%	Novartis	Irritable bowel syndrome	Mar-2002	Mon-20XX
171	Renagel	Sevelamer	559	23%	Genzyme, Roche, Chugai Pharmaceutical	Hyperphosphatemia	Oct-1998	Mon-20XX
172	Norditropin	Human growth hormone	557	19%	Novo Nordisk	Growth hormone deficiency	Jun-1909	Mon-20XX
173	Xopenex	Levalbuterol	555	29%	Sepracor	Bronchospasm	Mar-1999	Mon-20XX
174	Xenical	Orlistat	553	9%	Roche	Obesity	Jul-1998	Mon-20XX
175	Vasotec, Vaseretic	Enalapril	547	-12%	Merck & Co.	Hypertension	Dec-1985	Mon-20XX
176	Serevent	Salmeterol	538	-10%	GlaxoSmithKline	Asthma	Feb-1994	Mon-20XX
177	Cardura	Doxazosin	538	-8%	Pfizer	Hypertension	Nov-1990	Mon-20XX
178	Synthroid	Levothyroxine	534	-4%	Abbott Laboratories	Hypothyroidism	May-1909	Mon-20XX
179	Gonal-f	Follitropin alfa	533	-3%	Serono	Infertility	Oct-1995	Mon-20XX
180	Pepcid, Gaster	Famotidine	532	-10%	Astellas Pharma	Gastrointestinal disorders	Jun-1909	Mon-20XX
181	Cancidas	Caspofungin	530	-7%	Merck & Co.	Fungal infections	Jan-2001	Mon-20XX
182	Exelon	Rivastigmine	525	12%	Novartis	Alzheimer's disease	May-1998	Mon-20XX
183	Vfend	Voriconazole	515	30%	Pfizer	Fungal infections	Mar-2002	Mon-20XX
184	Amlodin	Amlodipine	506	4%	Dainippon Sumitomo	Hypertension, angina pectoris	n/a	Mon-20XX
185	Niaspan	Niacin	498	13%	Kos Pharmaceuticals	Cholesterol	Jul-1997	Mon-20XX
186	Neurontin	Gabapentin	496	-22%	Pfizer	Seizures	Dec-1993	Mon-20XX
187	Trizivir	Abacavir +Lamivudine +Zidovudine	496	-10%	GlaxoSmithKline	HIV infection	Nov-2000	Mon-20XX
188	Requip	Ropinirole	496	74%	GlaxoSmithKline	Parkinson disease	Sep-1997	Mon-20XX
189	Follistim, Puregon	Follitropin beta	482	8%	Akzo Nobel	Infertility	Sep-1997	Mon-20XX
190	Basen	Voglibose	476	-13%	Takeda Pharmaceutical	Hyperglycemia	Jun-1909	Mon-20XX
191	Levitra	Vardenafil	474	19%	Bayer, GlaxoSmithKline	Erectile dysfunction	Mar-2003	Mon-20XX
192	Glucophage	Metformin	459	-16%	Merck KGaA, Bristol-Myers Squibb	Type 2 diabetes	Dec-1994	Mon-20XX
193	Concor	Bisoprolol	455	4%	Merck KGaA	Hypertension	Jul-1992	Mon-20XX
194	Epzicom, Kixeva	Abacavir +Lamivudine	446	107%	GlaxoSmithKline	HIV infection	Aug-2004	Mon-20XX
195	Xatral	Alfuzosin	443	8%	Sanofi-Aventis	Benign prostatic hypertrophy	Jan-2000	Mon-20XX
196	Diflucan	Fluconazole	435	-13%	Pfizer	Fungal infections	Jan-1990	Mon-20XX
197	Thalomid	Thalidomide	433	12%	Celgene	Erythema nodosum leprosum	Jul-1998	Mon-20XX
198	Zantac	Ranitidine	429	-18%	GlaxoSmithKline	Gastrointestinal disorders	Jun-1983	Mon-20XX
199	Xolair	Omalizumab	429	32%	Roche, Genentech	Asthma	Jun-2003	Mon-20XX
200	Claritin	Loratadine	418	-5%	Schering-Plough, Shionogi & Co.	Allergic rhinitis	Apr-1993	Mon-20XX